U.S. flag An official website of the United States government.
Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

i

Characteristics of Aircrew Who Flew While Infectious With Mpox During the 2022 Multi-country Mpox Outbreak, United States, May 10-September 30, 2022.

Supporting Files
File Language:
English


Details

  • Alternative Title:
    Journal of Travel Medicine, 2024, v. 31, no. 8: Characteristics of Aircrew Who Flew While Infectious With Mpox During the 2022 Multi-country Mpox Outbreak, United States, May 10-September 30, 2022.
  • Journal Article:
    Journal of Travel Medicine
  • Personal Author:
  • Corporate Authors:
  • Description:
    Prior to 2022, mpox clade II cases in the United States occurred only in travellers from endemic countries or through exposure to imported animals.1 Human-to-human transmission of mpox during the global 2022 outbreak,2 which involved clade IIb, was primarily associated with sexual contact. In response to this outbreak, the U.S. Centers for Disease Control and Prevention (CDC) initially recommended aircraft contact investigations (CIs) when the CDC was notified of passengers or aircrew who were infectious with mpox during air travel.3 If the infected person was a crew member, passengers were not considered at elevated risk due to limited exposure time. Other aircrew members were considered to be at increased risk due to the potential for longer duration (≥3 h) of exposure in close proximity (within 6 ft) (direct CDC communication to airlines via the Federal Aviation Administration).

    Published data on aircrew who travelled while infectious with mpox are limited. Among 13 of the 44 aircrew previously identified and included in a recent Morbidity and Mortality Weekly Report (MMWR), no aircraft contacts were reported as developing mpox following exposure, based on aggregate health department (HD) outcome reporting.3 The current analysis characterized clinical characteristics of- and in-flight infection control measures taken by aircrew who travelled on U.S. domestic and inbound international commercial flights while infectious with mpox.
  • Content Notes:
    Author manuscript
  • Subjects:
  • Source:
    Journal of Travel Medicine, 2024, v. 31, no. 8
  • DOI:
  • ISSN:
    1195-1982 ; 1708-8305
  • Pubmed ID:
    39418330
  • Pubmed Central ID:
    PMC11973468
  • Document Type:
  • Funding:
  • Genre:
  • Place as Subject:
  • Pages in Document:
    6 pdf pages
  • Volume:
    31
  • Issue:
    8
  • Download URL:
  • File Type:
    Filetype[PDF - 218.33 KB]
  • Collection(s):
  • Main Document Checksum:
    urn:sha-512:7cbaa92f92d2ee73cd8db6f953db0721d99031aff83ebc1e91a04ddb9fc67903f65cdce812372e4da2ba71c366f16e5672b54aa995c745cd2376edc96b598f1c
File Language:
English
ON THIS PAGE
 Was this page helpful?
 Found an issue?
Send us an email at:
CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.